Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 5057-5066

  Jacobson, Amanda C ^a   Weis, Janis J ^a   Weis, John H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD11B ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; IMMUNOGLOBULIN G3; UNCLASSIFIED DRUG; ANTIBODY; ANTIGEN; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; IMMUNIZATION; INFLAMMATION; LYMPHOID TISSUE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; SPLEEN;

ANIMALS; ANTIBODIES; ANTIGENS; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; INFLAMMATION; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SPLEEN;

EID: 44449142985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.5057     Document Type: Article

References (51)

1. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4: 359-395.
2. Kohl, J. 2006. Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol. 586: 71-94.
3. Hawlisch, H., M. Wills-Karp, C. L. Karp, and J. Kohl. 2004. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41: 123-131.
4. Molina, H., T. Kinoshita, C. B. Webster, and V. M. Holers. 1994. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153: 789-795.
5. Kurtz, C. B., E. O'Toole, S. M. Christensen, and J. H. Weis. 1990. The murine complement receptor gene family: IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144: 3581-3591.
6. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173: 55-64.
7. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141: 457-463.
8. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153: 4448 - 4457.
9. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172.
10. Whipple, E. C., R. S. Shanahan, A. H. Ditto, R. P. Taylor, and M. A. Lindorfer. 2004. Analyses of the in vivo trafficking of stoichiometric doses of an anti - complement receptor 1/2 monoclonal antibody infused intravenously in mice. J. Immunol. 173: 2297-2306.
11. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
12. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713-723.
13. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
14. Reid, R. R., S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen, Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2002. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169: 5433-5440.
15. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169: 2126 - 2133.
16. -/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165: 3119-3127.
17. Zabel, M. D., M. Heikenwalder, M. Prinz, I. Arrighi, P. Schwarz, J. Kranich, A. von Teichman, K. M. Haas, N. Zeller, T. F. Tedder, et al. 2007. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and patho - genesis. J. Immunol. 179: 6144-6152.
18. Barrington, R. A., M. Zhang, X. Zhong, H. Jonsson, N. Holodick, A. Cherukuri,
19. S. K. Pierce, T. L. Rothstein, and M. C. Carroll. 2005. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J. Immunol. 175: 2859-2867.
20. Fischer, M. B., S. Goerg, L. Shen, A. P. Prodeus, C. C. Goodnow, G. Kelsoe, and M. C. Carroll. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280: 582-585.
21. Pepys, M. B. 1974. Role of complement in induction of antibody production in vivo: effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140: 126 - 145.
22. + suppressor T cell. J. Immunol. 134: 51-57.
23. Morgan, E. L., W. O. Weigle, and T. E. Hugli. 1982. Anaphylatoxin- mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J. Exp. Med. 155: 1412-1426.
24. Hojgaard, A., R. Close, D. M. Dunn, R. B. Weiss, J. J. Weis, and J. H. Weis. 2006. Altered localization of CXCL13 expressing cells in mice deficient in Pactolus following an inflammatory stimulus. Immunology 119: 212-223.
25. Czuprynski, C. J., J. F. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152: 1836-1846.
26. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167: 3190-3200.
27. Quigg, R. J., J. J. Alexander, C. F. Lo, A. Lim, C. He, and V. M. Holers. 1997. Characterization of C3-binding proteins on mouse neutrophils and platelets. J. Immunol. 159: 2438 - 2444.
28. Manis, J. P., M. Tian, and F. W. Alt. 2002. Mechanism and control of class - switch recombination. Trends Immunol. 23: 31-39.
29. Bergstedt-Lindqvist, S., C. Fernandez, and E. Severinson. 1981. A synergistic polyclonal response to dextran sulphate and lipopolysaccharide: immunoglobulin secretion and cell requirements. Scand. J. Immunol. 15: 439-448.
30. Rothman, P., S. Lutzker, B. Gorham, V. Stewart, R. Coffman, and F. W. Alt. 1990. Structure and expression of germline immunoglobulin γ3 heavy chain gene transcripts: implications for mitogen and lymphokine directed class-switching. Int. Immunol. 2: 621-627.
31. Gronowicz, E. S., C. Doss, F. Assisi, E. S. Vitetta, R. L. Coffman, and S. Strober. 1979. Surface Ig isotypes on cells responding to lipopolysaccharide by IgM and IgG secretion. J. Immunol. 123: 2049-2056.
32. Kansas, G. S. 1996. Selectins and their ligands: current concepts and controversies. Blood 88: 3259-3287.
33. Witthaut, R., A. Farhood, C. W. Smith, and H. Jaeschke. 1994. Complement and tumor necrosis factor-a contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo. J. Leukocyte Biol. 55: 105-111.
34. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-argi - nine metabolism. Nat. Rev. Immunol. 5: 641-654.
35. Bronte, V., E. Apolloni, A. Cabrelle, R. Ronca, P. Serafini, P. Zamboni, N. P. Restifo, and P. Zanovello. 2000. Identification of a CD11b+/Gr-1+/CD31 + myeloid progenitor capable of activating or suppressing CD8+ T cells. Blood 96:3838 - 3846.
36. Albrecht, E. A., and P. A. Ward. 2005. Complement-induced impairment of the innate immune system during sepsis. Curr. Infect. Dis. Rep. 7: 349-354.
37. Clancy, R. M., C. A. Dahinden, and T. E. Hugli. 1983. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc. Natl. Acad. Sci. USA 80: 7200-7204.
38. Eglite, S., K. Pluss, and C. A. Dahinden. 2000. Requirements for C5a receptor - mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J. Immunol. 165: 2183-2189.
39. Stankova, J., M. Rola-Pleszczynski, and C. M. Dubois. 1995. Granulocyte-mac - rophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 85: 3719 - 3726.
40. Ames, R. S., D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al. 2001. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J. Immunol 166: 6341-6348.
41. Tangye, S. G., A. Ferguson, D. T. Avery, C. S. Ma, and P. D. Hodgkin. 2002. Isotype switching by human B cells is division-associated and regulated by cytokines. J. Immunol. 169: 4298 - 4306.
42. Holguin, M. H., C. B. Kurtz, C. J. Parker, J. J. Weis, and J. H. Weis. 1990. Loss of human CR1 - and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. J. Immunol. 145: 1776 - 1781.
43. Paul, M. S., M. Aegerter, S. E. O'Brien, C. B. Kurtz, and J. H. Weis. 1989. The murine complement receptor gene family: analysis of mCRY gene products and their homology to human CR1. J. Immunol. 142: 582-589.
44. Morgan, B. P., and S. Meri. 1994. Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15: 369-396.
45. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204: 1463-1474.
46. Ezernitchi, A. V., I. Vaknin, L. Cohen-Daniel, O. Levy, E. Manaster, A. Halabi, E. Pikarsky, L. Shapira, and M. Baniyash. 2006. TCR 'zeta; down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J. Immunol. 177: 4763-4772.
47. Jordan, M. B., D. M. Mills, J. Kappler, P. Marrack, and J. C. Cambier. 2004. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 304: 1808 - 1810.
48. Riedemann, N. C., R. F. Guo, V. J. Sarma, I. J. Laudes, M. Huber-Lang, R. L. Warner, E. A. Albrecht, C. L. Speyer, and P. A. Ward. 2002. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168: 1919 - 1925.
49. Kock, M. A., B. E. Hew, H. Bammert, D. C. Fritzinger, and C. W. Vogel. 2004. Structure and function of recombinant cobra venom factor. J. Biol. Chem. 279: 30836-30843.
50. Fischer, W. H., and T. E. Hugli. 1997. Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-α, IL-6, and the polyclonal immune response. J. Immunol. 159: 4279-4286.
51. Nielsen, C. H., H. V. Marquart, W. M. Prodinger, and R. G. Leslie. 2001. CR2 - mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes. Immunology 104: 418 - 422.